Preoperative serum C-reactive protein and cholinesterase levels as risk factors of difficult laparoscopic cholecystectomy and severity of acute calculous cholecystitis: a retrospective observational study

This retrospective study of 198 patients undergoing early laparoscopic cholecystectomy for acute calculous cholecystitis identifies preoperative serum cholinesterase and C-reactive protein levels as independent predictors of difficult surgery, while C-reactive protein and male sex predict disease severity.

The Gist

Imagine your gallbladder is a small, angry balloon filled with stones. When it gets inflamed (a condition called Acute Calculous Cholecystitis), it's like a balloon that's been over-inflated and is about to pop. The standard treatment is to go in with a tiny camera (laparoscopy) and remove the balloon. Usually, this is a smooth, quick operation.

However, sometimes the inflammation is so severe, or the anatomy is so messy, that the surgery becomes a nightmare. Surgeons call this a "Difficult Laparoscopic Cholecystectomy" (DLC). It's like trying to untangle a knot in a dark room while wearing thick gloves. It takes longer, carries more risks, and might even require turning the tiny camera into a big open surgery.

The Big Question:
Before the surgeon even picks up the tools, can they look at the patient's blood work and say, "Oh, this is going to be a tough knot to untie" or "This patient is in deep trouble"?

The Study's Mission:
Researchers in China looked at 198 patients who had this surgery. They wanted to find a "crystal ball" in the blood test results. Specifically, they were interested in two things:

1. CRP (C-Reactive Protein): Think of this as the Fire Alarm. When your body is on fire (inflamed), this alarm goes off loud and clear.
2. ChE (Cholinesterase): Think of this as the Factory Output Gauge. Your liver is a factory that produces this protein. When the factory is stressed, sick, or overwhelmed by inflammation, it stops producing as much. The gauge drops.

What They Found (The "Aha!" Moments)

1. The "Tough Surgery" Predictor (DLC)
The researchers found that two specific blood markers were the best predictors of a difficult surgery:

• High CRP (The Loud Fire Alarm): If the alarm is screaming, the inflammation is bad, and the surgery will likely be hard.
• Low ChE (The Broken Factory Gauge): If the liver factory has slowed down production, it means the body is under massive stress. This was a new and surprising discovery. It's like seeing a car's engine light flicker; it tells the mechanic, "This engine is struggling, so the repair will be tricky."

2. The "How Sick is the Patient?" Predictor (Severity)
To predict how sick the patient actually is (not just how hard the surgery will be), they found:

• High CRP: Again, the louder the fire alarm, the sicker the patient.
• Being Male: Interestingly, being a man was an independent risk factor for having a more severe case of the disease. (Think of it like a specific model of car that tends to overheat more easily under certain conditions).

What Didn't Work?

The study looked at many other common markers, like the Neutrophil-to-Lymphocyte Ratio (NLR) or Procalcitonin (PCT). These are like other gauges on the dashboard. While they showed some signs of trouble, they weren't reliable enough to be the main warning lights. They were too noisy or inconsistent.

The Takeaway for Everyday Life

Imagine you are a surgeon standing in the operating room. Before you start, you check the patient's blood report.

• Scenario A: The report shows a High Fire Alarm (CRP) and a Low Factory Gauge (ChE).

  • The Surgeon's Thought: "Okay, this is a tough knot. I need to be extra careful, maybe bring extra help, and prepare for a longer surgery. I should warn the family that things might get complicated."

• Scenario B: The report shows a High Fire Alarm (CRP) and the patient is Male.

  • The Surgeon's Thought: "This patient is very sick. We need to monitor them closely for complications, even after the surgery is done."

In Simple Terms:
This study suggests that by simply looking at two numbers in a standard blood test—how high the inflammation is (CRP) and how well the liver is working (ChE)—doctors can get a much better "weather forecast" for the surgery. It helps them decide if they are walking into a light drizzle or a hurricane, allowing them to plan better and keep patients safer.

The Bottom Line:

• High CRP + Low ChE = Expect a Hard Surgery.
• High CRP + Male Patient = Expect a Severe Illness.

This helps doctors stop guessing and start planning with confidence.

Technical Summary

Title

Preoperative serum C-reactive protein and cholinesterase levels as risk factors of difficult laparoscopic cholecystectomy and severity of acute calculous cholecystitis: a retrospective observational study.

1. Problem Statement

• Clinical Context: Early laparoscopic cholecystectomy (ELC) is the gold standard treatment for Acute Calculous Cholecystitis (ACC). However, a significant subset of cases presents as Difficult Laparoscopic Cholecystectomy (DLC), characterized by prolonged operative time, conversion to open surgery, subtotal cholecystectomy, or complications.
• The Challenge: Accurately predicting DLC and the severity of ACC preoperatively is critical for surgical planning and risk stratification. Existing grading systems (e.g., Tokyo Guidelines 2018) and various biomarkers (WBC, NLR, PCT, CRP) have shown inconsistent results in predicting surgical difficulty.
• Knowledge Gap: The role of Serum Cholinesterase (ChE), a liver-synthesized enzyme often used as a marker for nutritional status and liver function, in predicting DLC and ACC severity remains unclear.

2. Methodology

• Study Design: Single-center, retrospective observational study.
• Setting: Dingxi People's Hospital, Gansu, China.
• Study Period: July 2023 to June 2025.
• Participants:
  • Total: 198 patients with ACC undergoing ELC.
  • Inclusion: Adults (>18 years), emergency admission.
  • Exclusion: Pancreatitis, obstructive jaundice, ascending cholangitis, tumors, hematological malignancies, or autoimmune diseases.
• Definitions:
  • DLC: Defined by operative time >90 min, drain placement, bile/stone spillage, conversion to open surgery, or subtotal cholecystectomy.
  • ACC Severity: Graded according to Tokyo Guidelines 2018 (TG18). Grade II was classified as "severe" (no Grade III cases were present in the cohort).
• Data Collection: Preoperative clinical data, laboratory parameters (including ChE, CRP, PCT, NLR, liver function tests), and imaging (Ultrasound/CT) were extracted from electronic medical records.
• Statistical Analysis:
  • Univariate analysis (Mann-Whitney, Chi-square, t-tests).
  • Multivariate logistic regression to identify independent predictors.
  • Significance level set at $P < 0.05$.

3. Key Contributions

• Identification of ChE as a Novel Predictor: This study is among the first to establish preoperative Serum Cholinesterase (ChE) as an independent predictor for both DLC and ACC severity.
• Differentiation of Predictors: The study distinguishes between factors predicting surgical difficulty (DLC) versus disease severity (ACC), showing that while CRP predicts both, ChE is specific to surgical difficulty, whereas male sex is specific to disease severity.
• Refinement of Biomarker Utility: The study clarifies that while many inflammatory markers (NLR, PCT, WBC) show univariate associations, they lose significance in multivariate models, highlighting the superior independent predictive value of CRP and ChE.

4. Results

• Cohort Characteristics:
  • 81 patients (40.9%) experienced DLC.
  • 102 patients (51.5%) had severe ACC.
  • No conversions to open surgery were recorded in this specific cohort.
• Univariate Findings:
  • DLC Group: Had significantly higher ALP, TBil, DBil, TBA, CRP, PCT, and hospital stay, but significantly lower ChE levels compared to non-DLC.
  • Severe ACC Group: Had higher WBC, monocytes, neutrophils, MLR, NLR, CRP, and gallbladder wall thickness, but lower ChE levels.
• Multivariate Logistic Regression (Independent Predictors):
  • For Difficult Laparoscopic Cholecystectomy (DLC):
    • CRP: Independent risk factor (OR 1.011, $P=0.010$).
    • ChE: Independent protective factor (OR 0.819, $P=0.036$). Lower ChE levels correlate with higher risk of DLC.
    • Note: Other markers like NLR and PCT were not independently associated.
  • For ACC Severity:
    • Male Sex: Independent risk factor (OR 2.132, $P=0.042$).
    • CRP: Independent risk factor (OR 1.017, $P=0.021$).
    • Note: ChE was not an independent predictor for severity in the multivariate model, though it was significant in univariate analysis.

5. Significance and Clinical Implications

• Risk Stratification: The combination of CRP and ChE offers a robust, low-cost preoperative tool for surgeons to anticipate difficult dissections. Low ChE levels may indicate systemic inflammation or hepatic synthetic dysfunction that complicates the "Critical View of Safety."
• Mechanism Insight: The study suggests that low ChE reflects a state of systemic inflammation (driven by cytokines like IL-6 and TNF-α suppressing hepatic synthesis) and potential malnutrition, which correlates with the technical difficulty of the surgery.
• Surgical Planning: Identifying patients with high CRP and low ChE preoperatively could prompt:
  • Allocation of more experienced surgeons.
  • Preparation for potential subtotal cholecystectomy or conversion.
  • Enhanced postoperative monitoring.
• Limitations: Single-center design, retrospective nature, lack of Grade III ACC cases, and absence of established optimal cut-off values for the biomarkers.
• Future Directions: The authors recommend multicenter prospective studies, potentially integrating these biomarkers with Artificial Intelligence models, to refine predictive algorithms for ACC management.